Virtu Financial LLC Summit Therapeutics Inc. Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$2.55 - $5.07 $9,807 - $19,499	3,846 Added 23.27%	20,372 $84,000
Q4 2023 Feb 26, 2024	BUY	$1.67 - $2.83 $27,598 - $46,768	16,526 New	16,526 $43,000
Q2 2023 Jul 27, 2023	BUY	$1.32 - $2.81 $20,677 - $44,018	15,665 Added 56.15%	43,563 $109,000
Q1 2023 May 01, 2023	BUY	$1.38 - $5.41 $3,198 - $12,540	2,318 Added 9.06%	27,898 $49,000
Q4 2022 Feb 15, 2023	BUY	$0.68 - $5.31 $17,394 - $135,829	25,580 New	25,580 $109,000
Q1 2022 May 17, 2022	SELL	$2.0 - $3.45 $27,298 - $47,089	-13,649 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$2.45 - $5.64 $33,440 - $76,980	13,649 New	13,649 $37,000
Q1 2021 May 19, 2021	SELL	$5.17 - $11.19 $56,016 - $121,243	-10,835 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$3.25 - $6.0 $35,213 - $65,010	10,835 New	10,835 $51,000

138

64.4M

1.06M

1.02M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $4.04B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.